Phase-Matching Gating for Isolated Attosecond Pulse Generation
Photonics · 06.10.2023 · 10 (10) · 1122
DOI: 10.3390/photonics10101122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Photonics, online erschienen am 06.10.2023. Verfasst von Vasily V. Strelkov und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RSF.
Abstract (Originalsprache)
We investigate the production of an isolated attosecond pulse (IAP) via the phase-matching gating of high-harmonic generation with intense laser pulses. Our study is based on the integration of the propagation equation for the fundamental and generated fields with nonlinear polarisation found via the numerical solution of the time-dependent Schrödinger equation. We study the XUV energy as a function of the propagation distance (or the medium density) and find that the onset of the IAP production corresponds to the change from linear to quadratic dependence of this energy on the propagation distance (or density). Finally, we show that the upper limit of the fundamental pulse duration for which IAP generation is feasible is defined by the temporal spreading of the fundamental pulse during the propagation. This nonlinear spreading is defined by the difference in the group velocities for the neutral and photoionised medium.
Förderung
- RSF
Zitieren
APA
Strelkov, V. V., & Khokhlova, M. A. (2023). Phase-Matching Gating for Isolated Attosecond Pulse Generation. Photonics, 10(10), 1122. https://doi.org/10.3390/photonics10101122
Vancouver
Strelkov VV, Khokhlova MA. Phase-Matching Gating for Isolated Attosecond Pulse Generation. Photonics. 2023;10(10):1122. doi:10.3390/photonics10101122
BibTeX
@article{Strelkov2023,
author = {Strelkov, Vasily V. and Khokhlova, Margarita A.},
title = {Phase-Matching Gating for Isolated Attosecond Pulse Generation},
journal = {Photonics},
year = {2023},
volume = {10},
number = {10},
pages = {1122},
doi = {10.3390/photonics10101122}
}
EUVIMED